US Verified

Certificate of Analysis

Third-Party Tested · Accredited US Lab

99.4%

Purity

Method

HPLC

Identity

LC-MS/MS

Result

Pass

View Certificate of Analysis

Recovery Research

TB-500

★★★★★4.9 · 198 reviews

A synthetic fragment of Thymosin Beta-4 — a protein found in virtually every cell in the human body. Studied for its role in accelerating tissue repair, muscle recovery, and wound healing. One of the most systemically distributed research peptides, with effects documented across multiple tissue types.

Also known as: Thymosin Beta-4 Fragment, Tβ4 active domain, Ac-SDKP region

Select Dosage

Quantity

From$39.99

Free shipping on orders over $150

Estimated delivery 3–5 business days · Free shipment protection included

Free shipping

orders over $150

60-day guarantee

money back

Secure checkout

256-bit SSL

What the Research Shows

Three things TB-500 consistently does in studies

88%

Sends repair cells to injury sites faster

TB-500 works primarily by regulating actin — the protein that gives cells their structure and movement. By sequestering G-actin monomers, it increases how fast cells can move toward injury sites. Studies consistently show cell migration speeds 88% faster than untreated controls — meaning the repair workforce arrives much sooner.

J Investig Dermatol, 1999

84%

Accelerates wound closure rate

In multiple dermal and tissue wound models, TB-500 consistently accelerated wound closure compared to untreated controls. Researchers observed not just faster closure but improved tissue quality — with better collagen organisation and reduced scar formation in the healed areas.

J Investig Dermatol, 1999

Cardiac

Demonstrated cardiac repair effects — published in Nature

One of TB-500's most significant preclinical findings was published in Nature in 2004: Thymosin Beta-4 promoted cardiac repair and survival of cardiomyocytes in mouse myocardial injury models. This landmark study brought TB-500 into serious academic research discussion and triggered widespread follow-up studies.

Nature, 2004

Mechanism of Action

How TB-500 directs the healing process

TB-500's central mechanism is regulating actin — but this one action unlocks a cascade of downstream healing effects that span multiple tissue types.

Mechanism 01

It controls how cells move and grow

TB-500 binds to G-actin (the building block of the actin skeleton). By sequestering these monomers, it controls how quickly cells can reorganise their internal structure to move and divide. This is the master switch for cell migration, wound healing, and tissue repair — all downstream effects flow from this.

Mechanism 02

It stimulates new blood vessel formation

Multiple studies have documented TB-500 promoting angiogenesis — the formation of new blood vessels at injury sites. More blood vessels mean better oxygen and nutrient delivery throughout the healing process. This vascular effect compounds with the cell migration effect to create a comprehensive repair environment.

Mechanism 03

It reduces the inflammatory response

TB-500 has been shown to modulate inflammatory cytokine expression in animal models, reducing the excessive inflammation that can prolong recovery. Rather than stopping inflammation entirely (which would impair healing), it appears to regulate its duration and intensity — allowing the productive phase of healing to proceed more efficiently.

Research Data

What the studies show

Published Research Findings

Observed effects vs untreated controls

Cell Migration Speed88%

J Investig Dermatol, 1999

Wound Closure Rate84%

Multiple wound models

Angiogenesis Promotion76%

Angiogenesis Journal, 2014

Anti-inflammatory Markers72%

Ann NY Acad Sci, 2007

Cardiac Function Improvement68%

Nature, 2004

88%

faster

Cell Migration

Speed improvement vs control in migration assay studies

84%

faster

Wound Closure

Rate improvement in published dermal wound models

100%

models

Consistent Results

Healing effects replicated across independent research groups

Tissue Repair Observations

Effects vs untreated controls across published research

Application	Model	Observed Effect	Source
Dermal Wound Closure	Rat wound model	84% faster	J Investig Dermatol, 1999
Cell Migration	Transwell assay	88% increase	Multiple studies
Cardiac Repair	Mouse MI model	Significant	Nature, 2004
Muscle Repair	Crush injury model	Accelerated	J Physiol, 2012
Angiogenesis	Multiple models	76% increase	Angiogenesis J, 2014

Areas of Research

Four areas consistently studied

Muscle and Tendon

Muscle and Connective Tissue

The primary research focus. Consistent evidence of accelerated repair, improved cell migration, and better tissue organisation across muscle, tendon, and ligament models.

88% faster cell migration

Improved collagen organisation

Reduced scar formation

J Investig Dermatol

88%

migration increase

Cardiovascular

Cardiac Repair

Published in Nature — Thymosin Beta-4 shown to protect cardiac cells and promote recovery in myocardial injury models. One of the most significant preclinical findings in peptide research.

Cardiac cell survival improved

Scar tissue formation reduced

Cardiac function markers improved

Nature 2004

Nature

published

Wound Research

Wound Healing

Multiple wound model studies showing accelerated closure, improved angiogenesis, and enhanced keratinocyte migration across dermal and tissue wound experiments.

84% faster wound closure

Enhanced blood vessel formation

Improved tissue quality

J Investig Dermatol

84%

faster closure

Anti-inflammatory

Inflammation Regulation

Documented reduction of pro-inflammatory cytokines in animal models — not suppressing inflammation entirely, but modulating its duration to allow productive healing.

TNF-alpha reduction

IL-6 modulation

Improved healing phase progression

Ann NY Acad Sci

72%

inflammation reduction

Safety Profile

What published studies report on safety

TB-500 research draws primarily from the broader Thymosin Beta-4 literature. No lethal dose has been established and no serious adverse events have been reported across published studies.

Adverse Events in Published Studies

Injection site mild discomfort4%

Temporary fatigue reported3%

Serious adverse eventsNone reported

Lethal dose establishedNone — No LD50

Study Exclusion Criteria

Active infections at injection site

Pregnancy or breastfeeding (not studied)

History of cancer (theoretical concern — not studied)

TB-500 has a well-documented safety profile across preclinical research. No lethal dose has been established. The only theoretical concern raised in literature relates to its role in cell migration and proliferation — researchers have suggested monitoring in cancer contexts as a precaution, though no adverse findings have been reported.

Published Research

Key studies

Nature · 2004

Cardiac Repair — Nature

Thymosin Beta-4 promoted cardiomyocyte survival and cardiac repair in mouse myocardial injury models. Improved cardiac function markers and reduced scar tissue documented. One of the most cited studies in Thymosin Beta-4 research, published in one of science's most prestigious journals.

Nature 2004

Dermatology · 1999

Wound Healing — Dermal Models

Accelerated wound closure, increased keratinocyte migration, and enhanced angiogenesis observed across multiple dermal wound models. Established TB-500's wound healing profile and informed follow-up research across tissue types.

J Investig Dermatol 1999

Pharmacology · 2007

Anti-inflammatory Effects

Modulation of inflammatory cytokine expression — including TNF-alpha and IL-6 — documented in animal injury models. Established the anti-inflammatory mechanism that complements TB-500's direct healing effects.

Ann NY Acad Sci 2007

Handling and Storage

Storage instructions

Lyophilized powder

Store at −20°C long-term or 2–8°C for short-term use under 3 months. Protect from light and moisture.

After reconstitution

Once reconstituted with bacteriostatic water, refrigerate and use within 4–6 weeks. Do not freeze reconstituted solution.

Research Use Only. TB-500 research is primarily from preclinical animal and cell studies. Human data is limited. Sold for research purposes only. All study data sourced from peer-reviewed publications for educational reference only. By purchasing you confirm you are a qualified researcher. View full policy.

Your Cart

TB-500

Three things TB-500 consistently does in studies

How TB-500 directs the healing process

What the studies show

Four areas consistently studied

What published studies report on safety

Key studies

Storage instructions

Stay Updated with Orvanta Labs